The University of Chicago Header Logo

Connection

Jeffrey Hubbell to Neovascularization, Physiologic

This is a "connection" page, showing publications Jeffrey Hubbell has written about Neovascularization, Physiologic.
  1. Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164. Proc Natl Acad Sci U S A. 2014 May 13; 111(19):6952-7.
    View in: PubMed
    Score: 0.443
  2. Extracellular matrix in angiogenesis: dynamic structures with translational potential. Exp Dermatol. 2011 Jul; 20(7):605-13.
    View in: PubMed
    Score: 0.364
  3. Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2. Biomaterials. 2004 Jul; 25(16):3245-57.
    View in: PubMed
    Score: 0.224
  4. Heterophilic interactions between cell adhesion molecule L1 and alphavbeta3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo. Angiogenesis. 2004; 7(3):213-23.
    View in: PubMed
    Score: 0.216
  5. Molecular properties of fibrin-based matrices for promotion of angiogenesis in vitro. Microvasc Res. 2001 Nov; 62(3):315-26.
    View in: PubMed
    Score: 0.186
  6. The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing. Blood. 2019 06 13; 133(24):2559-2569.
    View in: PubMed
    Score: 0.156
  7. Immunoisolation of murine islet allografts in vascularized sites through conformal coating with polyethylene glycol. Am J Transplant. 2018 03; 18(3):590-603.
    View in: PubMed
    Score: 0.142
  8. The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. Biomaterials. 2008 Apr; 29(11):1720-9.
    View in: PubMed
    Score: 0.071
  9. Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. Proc Natl Acad Sci U S A. 2006 Feb 21; 103(8):2506-11.
    View in: PubMed
    Score: 0.063
  10. Mechanical properties, proteolytic degradability and biological modifications affect angiogenic process extension into native and modified fibrin matrices in vitro. Biomaterials. 2005 Apr; 26(12):1369-79.
    View in: PubMed
    Score: 0.059
  11. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res. 2004 Apr 30; 94(8):1124-32.
    View in: PubMed
    Score: 0.055
  12. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J. 2003 Dec; 17(15):2260-2.
    View in: PubMed
    Score: 0.053
  13. Robust coupling of angiogenesis and osteogenesis by VEGF-decorated matrices for bone regeneration. Acta Biomater. 2022 09 01; 149:111-125.
    View in: PubMed
    Score: 0.049
  14. Covalently conjugated VEGF--fibrin matrices for endothelialization. J Control Release. 2001 May 14; 72(1-3):101-13.
    View in: PubMed
    Score: 0.045
  15. VEGFR-3 neutralization inhibits ovarian lymphangiogenesis, follicle maturation, and murine pregnancy. Am J Pathol. 2013 Nov; 183(5):1596-1607.
    View in: PubMed
    Score: 0.026
  16. The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165. Biomaterials. 2013 Aug; 34(24):5958-68.
    View in: PubMed
    Score: 0.026
  17. Proteolytic processing regulates placental growth factor activities. J Biol Chem. 2013 Jun 21; 288(25):17976-89.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.